HIV Infections
📧 Sign up to get email alerts when something new happens for HIV Infections.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-09-29Clinical Trial Update: Reducing HIV Risk Among Adolescents: Evaluating HEART for Teens [NA]
Completed clinical trial evaluating HEART for Teens to reduce HIV risk among adolescents; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-09-16Clinical Trial Update: Evaluating the Safety and Immunogenicity of HIV Clade C DNA Vaccine and MF59- or AS01B-Adjuvanted Clade C Env Protein Vaccines in Various Combinations in Healthy, HIV-Uninfected Adults [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating HIV clade C DNA vaccine and MF59- or AS01B-adjuvanted clade C Env protein vaccines in healthy, HIV-uninf…
-
CLINICAL_TRIALS trial_result · 2020-09-03Clinical Trial Update: Evaluation of Switching From Current cART to Triumeq With Adherence Support Will Enhance HIV Control in Vulnerable Populations [Phase 4]
Phase 4 trial evaluating switching from current cART to Triumeq with adherence support for HIV control in vulnerable populations completed.
-
CLINICAL_TRIALS trial_result · 2020-08-27Clinical Trial Update: Effect of GSK3640254 on the Pharmacokinetics of a Combination Oral Contraceptive [Phase 1]
Phase 1 trial assessing how GSK3640254 affects the pharmacokinetics of a combination oral contraceptive; study completed with posted results…
-
CLINICAL_TRIALS trial_result · 2020-08-25Clinical Trial Update: A Relative Bioavailability and Food-Effect Study of GSK3640254 Tablet and Capsule Formulations in Healthy Participants [Phase 1]
Phase 1 trial update investigating relative bioavailability and food effects of GSK3640254 tablet and capsule formulations in healthy partic…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2020-08-19Clinical Trial Update: CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery [Phase 4]
Phase 4 trial update on intensification with a CCR5 inhibitor to improve CD4+ T-cell recovery in HIV infections; results posted after comple…
-
CLINICAL_TRIALS trial_result · 2020-08-14Clinical Trial Update: Efficacy of 400 mg Efavirenz Versus Standard 600 mg Dose in HIV/TB Co-infected Patients [Phase 3]
Phase 3 trial comparing efficacy of 400 mg efavirenz versus standard 600 mg dose in HIV/TB co-infected patients; current status unknown.
-
CLINICAL_TRIALS trial_result · 2020-07-31Clinical Trial Update: Dolutegravir Pediatric Liquid Formulation Study [Phase 1]
Phase 1 study update for dolutegravir pediatric liquid formulation; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB Therapy [Phase 2]
Phase 2 trial comparing two doses of NVP (nevirapine) after initiating rifampin-containing TB therapy completed.
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Dose Reduction of Lopinavir in Children [Phase 2]
Phase 2 clinical trial updating dosing: dose reduction of Lopinavir in children with HIV infections has completed.
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Pharmacokinetic Study of 2 Doses of ATV/r OD + 2 NRTIs in Thai HIV-1 Infected Patients [Phase 1, Phase 2]
Phase 1/2 pharmacokinetic study assessing two doses of ATV/r once daily plus two NRTIs in Thai HIV-1 infected patients; completed.
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Pharmacokinetics of Generic Lopinavir/Ritonavir in Pregnant Women [Phase 2]
Phase 2 pharmacokinetics study of a generic lopinavir/ritonavir regimen in pregnant women with HIV completed.
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Hepatitis B Vaccination (HBV) in HIV Infected Children [Phase 2]
Phase 2 trial update on Hepatitis B vaccination in HIV-infected children completed.
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Pharmacokinetics (PK) and Safety of 2 Different Doses of Lopinavir/Ritonavir in in HIV/Tuberculosis (TB) Co-infected Patients Receiving Rifampicin Containing Anti-tuberculosis Therapy [Phase 2]
Phase 2 trial assessing pharmacokinetics and safety of two dose regimens of lopinavir/ritonavir in HIV/TB co-infected patients on rifampicin…
-
CLINICAL_TRIALS trial_result · 2020-07-17Clinical Trial Update: Second-line Therapy Antiretroviral in Patients Who Failed Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI) - Based Regimens [Phase 4]
Clinical trial update for second-line antiretroviral therapy in patients failing NNRTI-based regimens (Phase 4).
-
CLINICAL_TRIALS trial_result · 2020-07-16Clinical Trial Update: A Trial of Vitamins and HAART in HIV Disease Progression [Phase 3]
Phase 3 clinical trial evaluating vitamins in combination with HAART for HIV disease progression has completed recruitment.
-
CLINICAL_TRIALS trial_result · 2020-07-14Clinical Trial Update: Study to Evaluate Pharmacokinetics, Safety and Tolerability of Dolutegravir and Rilpivirine (JULUCA™) 50 Milligram (mg)/25 mg Tablets in Healthy Subjects of Japanese Descent [Phase 1]
Phase 1 pharmacokinetics and safety study of dolutegravir and rilpivirine (JULUCA) 50 mg/25 mg in healthy Japanese subjects completed; resul…
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Raltegravir + Lopinavir/Ritonavir Versus Efavirenz + Tenofovir + Emtricitabine in Treatment Naive Patients [Phase 2]
Phase 2 trial comparing raltegravir with lopinavir/ritonavir versus efavirenz-based regimen in treatment-naive HIV patients; completed with …
-
CLINICAL_TRIALS trial_result · 2020-06-11Clinical Trial Update: Efficacy, Safety and Tolerability Study of Long-acting Cabotegravir Plus Long-acting Rilpivirine (CAB LA + RPV LA) in Human-immunodeficiency Virus-1 (HIV-1) Infected Adults [Phase 3]
Phase 3 trial evaluating the efficacy, safety and tolerability of long-acting cabotegravir plus long-acting rilpivirine in adults with HIV-1…
-
CLINICAL_TRIALS trial_result · 2020-05-19Clinical Trial Update: A New APPROACH to HIV Testing: Adaptation of POCT for Pharmacies to Reduce Risk and Optimize Access to Care in HIV [NA]
A completed clinical trial evaluating a point-of-care HIV testing adaptation for pharmacies aimed at reducing risk and improving access to c…
-
CLINICAL_TRIALS trial_result · 2020-04-03Clinical Trial Update: Buprenorphine and Integrated HIV Care [Phase 4]
Phase 4 trial update on buprenorphine with integrated HIV care for substance-related disorders and HIV/AIDS.
-
CLINICAL_TRIALS trial_result · 2020-04-02Clinical Trial Update: Study to Evaluate the Effect of GSK3640254 on the Pharmacokinetics of Tenofovir Alafenamide/Emtricitabine [Phase 1]
Phase 1 trial assessing pharmacokinetics of Tenofovir Alafenamide/Emtricitabine with GSK3640254; completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-03-20Clinical Trial Update: Provision of HIV Self-Test Kit to Emergency Department Patients [NA]
Completed clinical trial evaluating provision of HIV self-test kits to emergency department patients; results posted in 2020.
-
CLINICAL_TRIALS trial_result · 2020-03-19Clinical Trial Update: Study to Evaluate the Pharmacokinetic (PK) Interactions Between GSK3640254 and Dolutegravir (DTG) [Phase 1]
Phase 1 study evaluating pharmacokinetic interactions between GSK3640254 and dolutegravir (DTG) in HIV infections; results posted after comp…
-
CLINICAL_TRIALS trial_result · 2020-02-21Clinical Trial Update: Safety and Efficacy of Reduced Versus Standard Dose Efavirenz (EFV) Plus Two Nucleotides in Antiretroviral-naïve Adults. [Phase 3]
Phase 3 trial comparing reduced-dose versus standard-dose efavirenz with two NRTIs in antiretroviral-naïve adults; completed with posted res…